Clark, NJ, June 2020
Strategic Delivery Solutions (“SDS Rx”), backed by HCI Equity Partners, announced it acquired Medical Delivery Services (“MDS” or the “Company”) on June 23, 2020. SDS Rx is a supply chain solutions provider focused on the last mile healthcare market, specializing in the movement of pharmaceuticals from wholesale distributors to pharmacies and from pharmacies to patients in facilities. The acquisition of MDS brings SDS Rx into new geographies and builds density in existing geographies. It also provides access to a new healthcare end market, radiopharmaceuticals. Financial terms of the transaction were not disclosed.
Headquartered in Tampa, Florida, MDS manages the transportation of radiopharmaceuticals, which are primarily used in diagnostic imaging and, in larger doses, to treat disease. The Company has a presence in 20 states, with a high concentration the Northeast and South.
“We are very excited about the acquisition of MDS and its unique position in the market. MDS brings specialization, experience and a skillful team to SDS Rx” said Drew Kronick, CEO of SDS Rx.
Doug McCormick, HCI Equity Managing Partner commented, “The acquisition of MDS combines two exceptional management teams with best in class capabilities in their respective markets and represents a significant achievement in SDS’ strategy to become a dominant pure play logistics provider to the healthcare industry.”
Jones Day served as legal counsel to SDS Rx.
About Strategic Delivery Solutions
SDS is the leading provider of logistics and delivery solutions focused on the last mile healthcare market. The Company specializes in the movement of pharmaceuticals from wholesale distributors to retail and pharmacies and from pharmacies to patients in facilities. For more information, please visit www.sds-rx.com.
At SDS Rx we provide the process, the information, and the delivery network to move medication from pharmacy to patient, and from wholesaler to pharmacy.
